Figure 5 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy

Figure 5 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy

<p>Systemic LOX promotes ECM remodeling following PTX chemotherapy. Bone marrow cells were flushed from Cre<sup>+/−</sup>LOX<sup>flox/flox</sup> or their control counterpart Cre<sup>−/−</sup>LOX<sup>flox/flox</sup> mice. The bone marrow cells wer...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Jozafina Haj-Shomaly (13010115) (author)
مؤلفون آخرون:	Avital Vorontsova (13010106) (author), Tamar Barenholz-Cohen (15203327) (author), Oshrat Levi-Galibov (9775532) (author), Mahesh Devarasetty (2045110) (author), Michael Timaner (13010109) (author), Ziv Raviv (361914) (author), Tim J. Cooper (13010127) (author), Shay Soker (400753) (author), Peleg Hasson (14924159) (author), Daphne Weihs (15203330) (author), Ruth Scherz-Shouval (14959181) (author), Yuval Shaked (37384) (author)
منشور في:	2025
الموضوعات:	Cancer Tumor Biology Therapeutic Research and Development Breast Cancer Chemotherapy Progression, Invasion & Metastasis Cell adhesion and extracellular matrix
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Figure 1 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure 2 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure 3 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure 4 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure 6 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure 7 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
حسب: Jozafina Haj-Shomaly (13010115)
منشور في: (2025)

Figure S1 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
حسب: Noam Cohen (17141553)
منشور في: (2025)

Figure S2 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
حسب: Noam Cohen (17141553)
منشور في: (2025)

Figure S3 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
حسب: Noam Cohen (17141553)
منشور في: (2025)

Concept Matrix Derived from the Systematic Literature Review on Trend Identification in Corporate Foresight
حسب: Jost Wiethölter (16542063)
منشور في: (2025)

Image 3_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.png
حسب: Domenico Sergi (435399)
منشور في: (2025)

Image 1_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.jpeg
حسب: Domenico Sergi (435399)
منشور في: (2025)

Image 2_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.jpeg
حسب: Domenico Sergi (435399)
منشور في: (2025)

Table 1_Extracellular products derived from Bacillus pumilus cultured on microalgal and cyanobacterial supplemented media: potential for controlling four specific aquaculture pathogens.docx
حسب: Jorge García-Márquez (3981194)
منشور في: (2025)

Data Sheet 1_Extracellular products derived from Bacillus pumilus cultured on microalgal and cyanobacterial supplemented media: potential for controlling four specific aquaculture pathogens.docx
حسب: Jorge García-Márquez (3981194)
منشور في: (2025)

Supplementary Table 3_Clonal distribution analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
حسب: Zijing Wang (17141626)
منشور في: (2025)

Supplementary Table 10_Pro metastatic pathways identified by classification analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 1_Primer and shRNA sequences_PCR cycles_Mycoplasma testing from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 2_Predictive power of genes and signatures_Patient cohorts GEO accession number from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 8_Genes identified by classification analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
حسب: Xiaohong Hong (22681698)
منشور في: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 4_Marker genes all and some per cluster_GO and curated pathways per cluster from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Table 5_Marker genes all and some per cluster no cell cycle_GO and curated pathways per cluster no cell cycle from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
حسب: Noor Jailkhani (16015810)
منشور في: (2025)

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
حسب: Noor Jailkhani (16015810)
منشور في: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
حسب: Noor Jailkhani (16015810)
منشور في: (2025)

Supplementary Figure S1 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis
حسب: Chong Kin Liam (15331321)
منشور في: (2025)

Supplementary Figure S2 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis
حسب: Chong Kin Liam (15331321)
منشور في: (2025)

Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis
حسب: Chong Kin Liam (15331321)
منشور في: (2025)

Supplementary Figure S4 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis
حسب: Chong Kin Liam (15331321)
منشور في: (2025)

The accuracy score change matrix following model development.
حسب: Uğur Ejder (22683228)
منشور في: (2025)

Transition metal doping for improving the fluorescence response of paralytic shellfish poisoning toxins upon pre-chromatographic derivatization
حسب: Paulo Vale (13163899)
منشور في: (2025)

Supplementary Table S2 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
حسب: Arun Kanakkanthara (14937731)
منشور في: (2025)

Supplementary Table S3 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
حسب: Arun Kanakkanthara (14937731)
منشور في: (2025)

Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
حسب: Dwight H. Owen (15034782)
منشور في: (2025)

Supplementary Figure 2 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
حسب: Dwight H. Owen (15034782)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_rbnh4l80lkljh1nj7cbhlgs7r5